Researchers at the University of Minnesota have identified, for the first time, a gene variation associated with systemic lupus erythematosus (SLE), a complex, inflammatory autoimmune disease that affects multiple organs. The gene variation, known as PTPN22, is found in approximately 16 percent (or one in six) of healthy Caucasians in the United States. However, nearly one in four (or 23 percent) lupus patients carry this variant, which has also now been associated with risk for type 1 diabetes and rheumatoid arthritis. The study is published in the September edition of the
American Journal of Human Genetics.
"This appears to be a very important gene for lupus," said Timothy W. Behrens, M.D., professor of medicine, Medical School, and principal investigator, "and this is the first time we have identified a variant that predisposes to many different autoimmune diseases. We hope that this discovery will lead to the identification of other genes associated with lupus and other immune disorders." Behrens believes that dozens of genes may be responsible for lupus and that discovering the combination of these genes will be important to developing better diagnosis and treatment of the disease.
In SLE, a person's immune system begins attacking its own tissues. Organs commonly targeted in SLE include the skin, kidneys, joints, lungs, and the central nervous system. The severity of disease and the response to therapy vary widely between patients, said Behrens, and this leads to significant challenges in the diagnosis and management of lupus. "If we know which genes predispose a person to lupus, we may be able to diagnose and treat the disease earlier," he said. "In addition to discovering which combination of genes lead to lupus and other immune diseases, we also hope this information will help us identify new drugs and therapies."
'"/>
Contact: Brenda Hudson
bhudson@umn.edu
612-624-5680
University of Chicago Press Journals
18-Aug-2004
Page: 1 Related biology news :1.
Lack of immune system protein prevents lupus-like condition in mice2.
Lupus Research Institute awards $3 million in novel research grants to further new science in lupus3.
High heart risk for lupus patients linked to death of cells lining blood vessels4.
Researchers determine a contributing genetic factor of photosensitivity in lupus patients5.
Researchers show autoantibodies occur before lupus in New England Journal of Medicine6.
Gene defect produces lupus-like disorder7.
Binding studies suggest drug development strategy for lupus8.
Treatment of lupus in mice may point the way to human treatment9.
Yale researchers shed light on B cells involvement in autoimmune diseases like lupus10.
FDA clears for market new diagnostic test for lupus11.
Biologists track down central cause of lupus